SCI时时刷

search
+
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites
Objectives: Left-sided colon cancer (LSCC) and right-sided colon cancer (RSCC) have shown distinc
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma
Objectives: Glioblastoma (GBM) is a fatal adult central nervous system tumor. Due to its high het
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy
Objectives: Androgen receptor–targeted therapies (ARTs) improve survival outcomes in patients wit
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
Objectives: Spinal metastases are common in metastatic cancer, affecting around 40% of patients.
Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments
Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments
With the global incidence of non-small cell lung cancer (NSCLC) on the rise, the development of inno
Radiotherapy Results in Locally Advanced Sinonasal Cancer: Turkish Society for Radiation Oncology, Head and Neck Study Group 01-005
Radiotherapy Results in Locally Advanced Sinonasal Cancer: Turkish Society for Radiation Oncology, Head and Neck Study Group 01-005
Objectives: This study aims to examine the treatment outcomes and related factors in locally adva
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction
Background: More than half of patients with early-stage estrogen receptor-positive (ER+) breast c
ACR–ARS Practice Parameter for Communication: Radiation Oncology
ACR–ARS Practice Parameter for Communication: Radiation Oncology
Background: This practice parameter was revised collaboratively by the American College of Radiol
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
Background: No consensus exists on the maximum dose delivered to the planning target volume (PTV)
ACR–ARS Practice Parameter for Radiation Oncology
ACR–ARS Practice Parameter for Radiation Oncology
Background: This practice parameter was revised collaboratively by the American College of Radiol
Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics
Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics
Chronic diarrhea and abdominal pain after radiotherapy continue to be a problem in cancer survivors.
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study
Background: In elderly patients with malignant central airway obstruction (MCAO), the treating ph
Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma
Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma
Background: In 2011, immunotherapy and targeted therapy revolutionized melanoma treatment. Howeve
Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial
Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial
Background: Creatine supplementation is an effective ergogenic nutrient for athletes, as well as
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography
Background: Diagnosis of malignant pulmonary nodules can greatly reduce the occurrence of lung ca
ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals
ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals
Objectives: This practice parameter was revised collaboratively by the American College of Radiol
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines
For patients with locoregionally confined pancreatic ductal adenocarcinoma (PDAC), margin-negative s
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018
Objectives: This study evaluated real-world treatment patterns of approved bone-targeting agents
Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non–Small Cell Lung Cancer on Maintenance Systemic Therapy
Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non–Small Cell Lung Cancer on Maintenance Systemic Therapy
Objectives: This study aims to evaluate the efficacy and toxicity of radiotherapy (RT) to oligopr
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum
In “Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior” published in the Ameri...
SBRT vs. Y90: HCC Treatment Outcomes and Costs
SBRT vs. Y90: HCC Treatment Outcomes and Costs
Objectives: Stereotactic Body Radiotherapy (SBRT) and Yttrium-90 (Y90) are among the ablative the
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression
Objective: The safety of single-treatment stereotactic radiosurgery (SRS) for vestibular schwanno
Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair Analysis
Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair Analysis
Background: Concurrent chemoradiotherapy based on hyperfractionated accelerated radiotherapy (HAR
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab
Objectives: In randomized clinical trials in patients with hepatocellular cancer (HCC), combinati
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba
Objectives: Although metastatic breast cancer (MBC) is considered incurable, human epidermal grow
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor: A 20-Year Experience
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor: A 20-Year Experience
Background: As radiation therapy (RT) for Wilms tumor (WT) evolves with more conformal techniques
Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC
Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC
Triple-negative breast cancer is characterized by high lethality attributed to factors such as chemo
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-Eligible
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-Eligible
Introduction: Insurance denials for clinical trials serve as a pertinent barrier for patients to
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System
Objectives: Pancreatic cancer is often diagnosed at advanced stages with high-case fatality. Many
Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell Tumors: A Population-based Study
Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell Tumors: A Population-based Study
Background: Studies addressing second hematologic malignancies (SHMs) in patients with primary me
阅读更多
format_indent_increase